NEXUS BIOPHARMA INC Proceeds from Convertible Debt
NEXUS BIOPHARMA INC reported Proceeds from Convertible Debt of $100.00 thousand for the 3-month period ending 2017-05-31, per its 10-Q filed 2017-10-27.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromConvertibleDebt · last filed 2017-10-27
- NEXUS BIOPHARMA INC proceeds from convertible debt for the quarter ending 2017-05-31 was $100.00K.
- NEXUS BIOPHARMA INC proceeds from convertible debt for fiscal 2016 was $60.00K.
| Period end | Proceeds from Convertible Debt 3 month | Proceeds from Convertible Debt 12 month |
|---|---|---|
| 2017-05-31 | $100.00K 10-Q · filed 2017-10-27 | |
| 2016-02-29 | $60.00K 10-K · filed 2017-07-05 |